Changkun Zhu

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Endometrial Cancer

Polycyclic Aromatic Hydrocarbons

Top Venues

Journal of gynecologic oncology

Translational cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Jian Zou, Yang Li, Tingting Chen, Changkun Zhu
An E7-retinoblastoma protein pathway mechanism may account for the higher carcinogenic ability of HPV16 over HPV58 in cervical cancer. Translational cancer research 13 (4) (2024)
Jian Zou, Yang Li, Tingting Chen, Changkun Zhu
An E7-retinoblastoma protein pathway mechanism may account for the higher carcinogenic ability of HPV16 over HPV58 in cervical cancer. Translational cancer research 13 (4) (2024)
Yang Li, Changkun Zhu, Hongyu Xie, Yaxia Chen, Wei-Guo Lv, Xing Xie, Xinyu Wang
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT). Journal of gynecologic oncology 34 (2) (2023)
Yang Li, Changkun Zhu, Hongyu Xie, Yaxia Chen, Wei-Guo Lv, Xing Xie, Xinyu Wang
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT). Journal of gynecologic oncology 34 (2) (2023)
Yang Li, Changkun Zhu, Hongyu Xie, Yaxia Chen, Wei-Guo Lv, Xing Xie, Xinyu Wang
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT). Journal of gynecologic oncology 34 (2) (2023)
Yang Li, Changkun Zhu, Hongyu Xie, Yaxia Chen, Wei-Guo Lv, Xing Xie, Xinyu Wang
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT). Journal of gynecologic oncology 34 (2) (2023)
Yang Li, Changkun Zhu, Hongyu Xie, Yaxia Chen, Wei-Guo Lv, Xing Xie, Xinyu Wang
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT). Journal of gynecologic oncology (2023)
Jian Zou, Yang Li, Changkun Zhu
Laparoscopy with transverse-abdominal extra-fascial hysterectomy for early-stage endometrial carcinoma, obesity, and large uterus: A case report. Medicine 102 (45) (2023)